RLYB vs TM · rev $212.0K vs P/E 9.7, rev $234.60B
Rallybio Corp (RLYB) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Rallybio Corp (RLYB) is a biotechnology company listed on US.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported RLYB revenue for 2026-06-30 was $212.0K. Net income was $35.4M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RLYB currently screens at market cap $13.8M.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
RLYB currently screens at market cap $13.8M. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the RLYB and TM stock pages for the full models.
Not investment advice.